ArticleInternational journal of oncology2020

Epigenetic activation of FOXF1 confers cancer stem cell properties to cisplatin‑resistant non‑small cell lung cancer.

Jian Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.